Background The incidence of elevated liver chemistries and the presence of pre‐existing
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …

ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of
patients infected worldwide and indirectly affecting even more individuals through disruption …

Background & Aims Liver enzyme abnormalities are common in patients with coronavirus
disease 2019 (COVID-19). Whether or not severe acute respiratory syndrome coronavirus 2 …

In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …

COVID-19 is a systemic infection that exerts significant impact on the metabolism. Yet, there
is little information on how SARS-CoV-2 affects metabolism. Using NMR spectroscopy, we …

In coronavirus disease 2019 (COVID‐19), higher morbidity and mortality are associated with
age, male gender, and comorbidities, such as chronic lung diseases, cardiovascular …

COVID-19 is a pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). Early reported symptoms include fever, cough, and respiratory symptoms …

The coronavirus pandemic has changed the priorities of the whole medical society. During
the clinical course of COVID-19, it has been observed that hepatic injury occurs in a …

COVID-19 is a global threat that has spread since the end of 2019, causing severe clinical
sequelae and deaths, in the context of a world pandemic. The infection of the highly …

One of the major challenges currently faced by global health systems is the prolonged
COVID-19 syndrome (also known as “long COVID”) which has emerged as a consequence …